(SXIPEX) iShares STOXX Europe 600 - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: EUR • Type: Etf • ISIN: DE000A0H08K7

Banking, Insurance, Investments

Description: SXIPEX iShares STOXX Europe 600

The iShares STOXX Europe 600 Insurance UCITS ETF (DE) is a sector-specific exchange-traded fund that tracks the Morningstar Global Financial Services Index, focusing on insurance companies within the European market. This ETF offers investors a targeted exposure to the European insurance sector, allowing for diversified investment within this specific industry.

Analyzing the ETFs characteristics, its clear that it is designed for investors seeking to capitalize on the performance of European insurance companies. The fund is listed in Switzerland and is categorized under Sector Equity Financial Services, indicating its specialized investment scope. Its Assets Under Management (AUM) stand at 87.00M EUR, suggesting a moderate level of investor interest.

From a technical standpoint, the ETF has shown a positive trend, with its last price recorded at 49.50 EUR. The short-term (SMA20) and medium-term (SMA50) moving averages are 48.37 and 46.58, respectively, indicating an upward trend as the current price is above both averages. The long-term trend (SMA200) is 38.55, further supporting the notion of a significant upward movement over the past 200 trading days. The Average True Range (ATR) is 0.70, or 1.42% of the last price, suggesting moderate daily volatility. The 52-week high and low are 50.17 and 27.15, respectively, showing a substantial recovery or growth from the low point.

Combining technical and fundamental data for a forecast, the upward trend indicated by the moving averages and the recent price action suggests potential for continued growth, driven by the recovery and performance of the European insurance sector. However, the moderate volatility, as indicated by the ATR, suggests that there may be fluctuations along the way. Given the AUM and the specific focus on the insurance sector, investors should monitor the sectors outlook and macroeconomic factors that could influence insurance companies performance. A potential forecast could involve a continued upward trend, with possible targets near or above the 52-week high, assuming the sector continues to perform well and investor sentiment remains positive.

Investors considering this ETF should weigh the potential benefits of targeted exposure to the European insurance sector against the risks associated with sector-specific investments and the inherent volatility of the financial markets. A thorough analysis of the underlying index constituents, the overall market conditions, and the macroeconomic environment will be crucial in making an informed investment decision.

Additional Sources for SXIPEX ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

SXIPEX ETF Overview

Market Cap in USD 103m
Category Sector Equity Financial Services
IPO / Inception 2002-07-08

SXIPEX ETF Ratings

Growth Rating 58.9
Fundamental -
Dividend Rating 0.0
Rel. Strength -3
Analysts -
Fair Price Momentum 50.81 EUR
Fair Price DCF -

SXIPEX Dividends

Currently no dividends paid

SXIPEX Growth Ratios

Growth Correlation 3m 46.1%
Growth Correlation 12m 97.5%
Growth Correlation 5y 94%
CAGR 5y 49.82%
CAGR/Max DD 5y 2.40
Sharpe Ratio 12m 1.86
Alpha 42.83
Beta 0.504
Volatility 18.92%
Current Volume 0k
Average Volume 20d 0.2k
What is the price of SXIPEX shares?
As of July 06, 2025, the stock is trading at EUR 48.48 with a total of 0 shares traded.
Over the past week, the price has changed by -0.02%, over one month by -2.98%, over three months by +9.15% and over the past year by +25.43%.
Is iShares STOXX Europe 600 a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, iShares STOXX Europe 600 (SW:SXIPEX) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 58.85 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SXIPEX is around 50.81 EUR . This means that SXIPEX is currently overvalued and has a potential downside of 4.81%.
Is SXIPEX a buy, sell or hold?
iShares STOXX Europe 600 has no consensus analysts rating.
What are the forecasts for SXIPEX share price target?
According to our own proprietary Forecast Model, SXIPEX iShares STOXX Europe 600 will be worth about 57.1 in July 2026. The stock is currently trading at 48.48. This means that the stock has a potential upside of +17.74%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 57.1 17.7%